To the content
4 . 2024

Implantation of a universal self-expanding aortic bioprosthesis (transcatheter and sutureless) for minimally invasive surgery into a silicone 3-dimensional model of the aortic root

Abstract

Aim – to test the first domestic universal transcatheter bioprosthesis for aortic valve replacement in a 3D model of the aortic root in an in vitro experiment.

Material and methods. Implantation of a prototype transcatheter aortic bioprosthesis with a self-expanding nitinol frame was performed in the aortic valve position of a silicone 3D model of the aortic root. The model was created using multislice computed tomography data from a patient with severe degenerative aortic stenosis.

Results. Adequate orientation of the ventricular and aortic components of the bioprosthesis was achieved, along with reliable circumferential coverage and adherence of the annular part of the frame, ensuring stable fixation of the prosthesis in the aortic position of the artificial aortic root.

Conclusion. The prototype of the universal aortic bioprosthesis demonstrated effectiveness when implanted into the aortic valve position of the 3D aortic root model.

Keywords:aortic valve; sutureless aortic prosthesis; transcatheter aortic valve replacement; TAVI

Funding. The study was carried out within the Russian Science Foundation grant No. 23-15-00434.

Conflict of interest. The authors declare no conflict of interest.

For citation: Bogachev-Prokophiev A.V., Zalesov A.S., Sharifulin R.M., Vladimirov S.V., Afanasyev A.V., Tsaroev B.S., Islomov A.A., Chernyavsky A.M. Implantation of a universal self-expanding aortic bioprosthesis (transcatheter and sutureless) for minimally invasive surgery into a silicone 3-dimensional model of the aortic root. Clinical and Experimental Surgery. Petrovsky Journal. 2024; 12 (4): 7–12. DOI: https://doi.org/10.33029/2308-1198-2024-12-4-7-12 (in Russian)

References

1.     Van Hemelrijck M., Taramasso M., De Carlo C., Kuwata S., Regar E., Nietlispach F., et al. Recent advances in understanding and managing aortic stenosis. F1000Res. 2018; 7: 58. DOI: https://doi.org/10.12688/f1000research.11906.1

2.     Iung B., Delgado V., Rosenhek R., Price S., Prendergast B., Wendler O., et al.; EORP VHD II Investigators. Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II Survey. Circulation 2019; 140: 1156–69.

3.     Dahl J.S., Eleid M.F., Michelena H.I., Scott C.G., Suri R.M., et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging. 2015; 8: e002917.

4.     Taniguchi T., Morimoto T., Shiomi H., Ando K., Kanamori N., Murata K., et al.; CURRENT AS Registry Investigators. Prognostic impact of left ventricular ejection fraction in patients with severe aortic stenosis. JACC Cardiovasc Interv. 2018; 11: 145–7.

5.     Leon M.B., Smith C.R., Mack M., Miller D.C., Moses J.W., Svensson L.G., et al.; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363 (17): 1597–607. DOI: https://doi.org/10.1056/NEJMoa1008232

6.     Smith C.R., Leon M.B., Mack M.J., Miller D.C., Moses J.W., Svensson L.G., et al.; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364 (23): 2187–98. DOI: https://doi.org/10.1056/NEJMoa1103510

7.     Adams D.H., Popma J.J., Reardon M.J., Yakubov S.J., Coselli J.S., Deeb G.M., et al.; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014; 370 (19): 1790–8. DOI: https://doi.org/10.1056/NEJMoa1400590

8.     Thyregod H.G., Steinbrüchel D.A., Ihlemann N., Nissen H., Kjeldsen B.J., Petursson P., et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015; 65 (20): 2184–94. DOI: https://doi.org/10.1016/j.jacc.2015.03.014 Epub 2015 Mar 15.

9.     Faggiano P., Antonini-Canterin F., Baldessin F., Lorusso R., D’Aloia A., Cas L.D. Epidemiology and cardiovascular risk factors of aortic stenosis. Cardiovasc Ultrasound. 2006; 4: 27. DOI: https://doi.org/10.1186/1476-7120-4-27  

10. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013; 127 (1): e6–245. DOI: https://doi.org/10.1161/CIR.0b013e31828124ad Epub 2012 Dec 12.

11. Thaden J.J., Nkomo V.T., Enriquez-Sarano M. The global burden of aortic stenosis. Prog Cardiovasc Dis. 2014; 56 (6): 565–71. DOI: https://doi.org/10.1016/j.pcad.2014.02.006  

12. Ahn C.B., Lee S.I., Choi C.H., Park C.H., Park K.Y., Lee J.W., et al. Feasibility of a 3D printed patient-specific model system to determine hemodynamic energy delivery during extracorporeal circulation. ASAIO J. 2018; 64 (3): 309–17. DOI: https://doi.org/10.1097/MAT.0000000000000638

13. Giannopoulos A.A., Steigner M.L., George E., Barile M., Hunsaker A.R., Rybicki F.J., et al. Cardiothoracic applications of 3-dimensional printing. J Thorac Imaging. 2016; 31 (5): 253–72. DOI: https://doi.org/10.1097/RTI.0000000000000217

14. Lim H.G., Jeong S., Kim G.B., Lee W., Son K.H., Kim Y.J. Next-generation transcatheter aortic valve implantation. JTCVS Open. 2020; 3: 14–24. DOI: https://doi.org/10.1016/j.xjon.2020.06.008 PMID: 36003870; PMCID: PMC9390526.

15. Farooqi K.M., Mahmood F. Innovations in Preoperative Planning: Insights into Another Dimension Using 3D Printing for Cardiac Disease. J Cardiothorac Vasc Anesth. 2018; 32 (4): 1937-1945. DOI: 10.1053/j.jvca.2017.11.037 

16. Thourani V.H., Suri R.M., Gunter R.L., Sheng S., O’Brien S.M., Ailawadi G., et al. Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients. Ann Thorac Surg. 2015; 99 (1): 55–61.

17. Gleason T.G., Reardon M.J., Popma J.J., Deeb G.M., Yakubov S.J., Lee J.S., et al.; CoreValve US Pivotal High Risk Trial Clinical Investigators. 5-year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients. J Am Coll Cardiol. 2018; 72 (22): 2687–96.

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Sergey L. Dzemeshkevich
MD, Professor (Moscow, Russia)
geotar-digit

Journals of «GEOTAR-Media»